A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours
Clinical trial NCT05804526 · UNKNOWN
Trial details
- NCT number
- NCT05804526
- Sponsor
- RemeGen Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2025-05-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.